Risk of Infectious Complications in Hemato-Oncological Patients Treated with Kinase Inhibitors

by Mark Reinwald, Tobias Boch, Wolf-Karsten Hofmann, Dieter Buchheidt
Published 2015-01-01

Risk of Infectious Complications in Hemato-Oncological Patients Treated with Kinase Inhibitors

by Mark Reinwald, Tobias Boch, Wolf-Karsten Hofmann, Dieter Buchheidt
Published 2016-04-01

Clinical Response to the CD95-Ligand Inhibitor Asunercept Is Defined by a Pro-Inflammatory Serum Cytokine Profile

by Aleksandar Radujkovic, Tobias Boch, Florian Nolte, Daniel Nowak, Claudia Kunz, Alexandra Gieffers, Carsten Müller-Tidow, Peter Dreger, Wolf-Karsten Hofmann, Thomas Luft
Published 2020-12-01

Comparison of Two Molecular Assays for Detection and Characterization of Aspergillus fumigatus Triazole Resistance and Cyp51A Mutations in Clinical Isolates and Primary Clinical Sa...

by Patricia Postina, Julian Skladny, Tobias Boch, Oliver A. Cornely, Oliver A. Cornely, Axel Hamprecht, Peter-Michael Rath, Jörg Steinmann, Oliver Bader, Thomas Miethke, Anne Dietz, Natalia Merker, Wolf-Karsten Hofmann, Dieter Buchheidt, Birgit Spiess
Published 2018-03-01

Identification of leukemic and pre-leukemic stem cells by clonal tracking from single-cell transcriptomics

by Lars Velten, Benjamin A. Story, Pablo Hernández-Malmierca, Simon Raffel, Daniel R. Leonce, Jennifer Milbank, Malte Paulsen, Aykut Demir, Chelsea Szu-Tu, Robert Frömel, Christoph Lutz, Daniel Nowak, Johann-Christoph Jann, Caroline Pabst, Tobias Boch, Wolf-Karsten Hofmann, Carsten Müller-Tidow, Andreas Trumpp, Simon Haas, Lars M. Steinmetz
Published 2021-03-01